Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Among those with moderate-to-advanced chronic kidney disease, the relationship between blood pressure and cardiovascular disease appears ‘U’-shaped, but is loglinear in apparently healthy adults. The Study of Heart and Renal Protection randomized 9270 patients with chronic kidney disease to simvastatin/ezetimbe versus matching placebo, and measured blood pressure at each follow-up visit. Cox regression was used to assess the association between blood pressure and risk of cardiovascular disease among:(i) those with a self-reported history of cardiovascular disease; and (ii) those with no such history and, based on plasma troponin-I concentration, a low probability of subclinical cardiac disease. 8666 participants had a valid baseline blood pressure and troponin-I measurement and 2188 had at least one cardiovascular event during follow-up. After adjustment for relevant confounders, the association between systolic blood pressure and cardiovascular events was ‘U’-shaped, but among participants without evidence of prior cardiovascular disease, there was a positive loglinear association throughout the range of values studied. Among those with the lowest probability of subclinical cardiac disease, each 10mmHg higher systolic blood pressure corresponded to a 27% increased risk of cardiovascular disease (hazard ratio 1.27, 95% confidence interval 1.11-1.44). In contrast, the relationship between diastolic blood pressure and cardiovascular risk remained ‘U’-shaped irrespective of cardiovascular disease history or risk of subclinical disease. In conclusion, the lack of a clear association between systolic blood pressure and cardiovascular risk in this population appears attributable to confounding, suggesting that more intensive systolic blood pressure reduction may be beneficial in such patients.


Journal article




American Heart Association

Publication Date